Ledger.Open graph →
SEC Form D · filed January 26, 2023

Linnaeus Therapeutics, Inc

Offering
$3.1M
Sold
$3.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
HADDONFIELD, NJ
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (6)

Nicholas T. Iatropoulos · Haddonfield, NJDirectorPatrick T. Mooney · Haddonfield, NJExec · DirectorTodd T. Thomson · Haddonfield, NJDirectorMichael D. Poisel · Haddonfield, NJDirectorWayne D. Linsley · Englewood Cliffs, NJDirectorAlta Fox Connor GenPar, LP · FORT WORTH, TXDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗